GHTC sends FY21 letter to OMB
GHTC sent a letter to the White House Office of Management and Budget (OMB), calling for the administration to sustain and protect global health R&D in the fiscal year 2021 (FY21) budget.
GHTC sent a letter to the White House Office of Management and Budget (OMB), calling for the administration to sustain and protect global health R&D in the fiscal year 2021 (FY21) budget.
GHTC submitted written testimony to key Senate appropriations subcommittees urging them to sustain and protect global health R&D funding in the fiscal year 2020 (FY20) budget.
GHTC joined other advocates in endorsing the Comprehensive TB Elimination Act of 2019, which would enhance tuberculosis (TB) R&D at the National Institutes of Health and facilitate coordination of late stage R&D of new TB diagnostic, treatment, and prevention tools with the Biomedical Advanced Research and Development Authority.
A statement by GHTC and partners calling on the World Health Organization and member states to close the US$1.3 billion gap in annual tuberculosis (TB) R&D funding was made at the 72nd World Health Assembly. The statement urges countries to invest in the development of new medicines and technologies to treat multidrug-resistant TB and to facilitate rapid and equitable access to these interventions.